ReviewJournal for immunotherapy of cancer2018

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond.

Jason Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.